Biogen (BIIB) – Hot Downgrades
-
Sage, Biogen receive setback despite FDA approval of postpartum depression drug. This is why
-
BofA Securities Downgrades Biogen (BIIB) to Underperform
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BIIB Stock Lookup